(Q43862277)

English

Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Goto M

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Okamoto Y

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yamamoto M

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Aki H

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1711-1720

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Dissolution of Cholesterol Gallstones by Chenodeoxycholic Acid

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Bile formation and hepatic plasma membrane composition in guinea-pigs and rats

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Degradation of bile salts by human intestinal bacteria

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Kinetics of 5-aminosalicylic acid after jejunal instillation in man.

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

The human intestinal microflora

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Sulfasalazine. Adverse effects and desensitization

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Carrageenan-induced ulceration of the large intestine in the guinea pig.

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

The evaluation of some red marine algae as a source of carrageenan and of its k- and lambda-components

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Crosslinked dextran--a new capsule material for colon targeting of drugs

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Nephrotoxic lesions from 5-aminosalicylic Acid.

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

In vivo drug release behavior in dogs from a new colon-targeted delivery system

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Rapid production of ulcerative disease of the colon in newly-weaned guinea-pigs by degraded carrageenan

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

5-amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis

1 reference

https://api.crossref.org/works/10.1211%2F0022357011778115

21 January 2018

Identifiers

10.1211/0022357011778115

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43862277&oldid=2103982544"